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Abstract
Hepatitis is disease of the liver caused by the infectious and non-infectious agents.
The aim of study was to analyze the prevalence of HBV and HCV among voluntary blood donors
in Kosovo, during 2000–2003.
The data from National Center for Blood Transfusion of Kosovo were collected and analyzed
through descriptive and comparative epidemiological method of retrospective study. All samples
were tested by ELISA test.
Out of 70348 samples of the blood donors, 3145 were positive. From overall positive samples,
2939 were HBV positive, 192 HCV positive while 14 samples were positive for both viruses.
The HBV prevalence among the blood donors of Kosovo is 4.2%, which range Kosovo to the
second zone according to the CDC classification of the geographical spread of the HBV infection.
The HCV prevalence among the blood donors in Kosovo is 0.3%. Compared to the other European
countries this level of prevalence is relatively low.
Age group 30–39 years old was presented with 34.8% of cases. The higher number was among the
workers, 842 or 26.8%.
Based on the results we can conclude that Kosovo have the similar prevalence for HBV and HCV
infections as other South East European countries.
Introduction
Hepatitis is term to describe a nonspecific liver inflamma-
tion [1-5]. Until now are known 8 types of hepatitis: A, B,
C, D, E, F, G and TT. Hepatitis B and C are similar types of
liver infection, which are mostly spread through blood
and blood products.
The possibility of hepatitis transmission through blood
and blood products were known since 1950 [6-9].
Hepatitis B virus is an AND virus from hepadnaviridae
family. Hepatitis C virus is an ARN virus with lipid coat
similar to flaviviridae family.
Infected person or asymptomatic carriers with viral hepa-
titis B and C are only reservoir of infection [8-12].
Researches show as that world prevalence of HBsAg carri-
ers is from 0.1% till 20% with high percentage in tropical
countries [5,12].
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The prevalence of anti HCV antibody is variety in different
world countries with high number reported for Egypt.
Aim of study
The aim of a study was to analyze the prevalence of the
HBsAg and anti-HCV antibodies in Kosovo during the
period 2000–2003. The possible influence of the various
factors on the prevalence was analyzed too. The preva-
lence was compared with the data available on European
and World level.
Material and methodology
Data from databank of the voluntary blood donors of the
National Blood Bank in Pristina, as well the data from the
databank of the Transfusion Centers in regional Hospitals
in Peja, Gjakova, Prizren and Gjilan were used in this
study. The analyzed period was from 2000 – 2003.
The method of study was descriptive and comparative in
retrospective aspect.
The T – test and Χ2- test were used to analyze the signifi-
cance of the results.
All samples were tested by ELISA test.
Results
The results of the study showed that from 70348 samples
of the blood donated by the blood donors, 3145 were
positive. From overall positive samples, 2939 were HBV
positive, 192 HCV positive, while in 14 samples both
viruses were discovered (Table 1 and Figure 1)
Male sex is represented with higher number of infected
persons with HBV and HCV. From overall infected per-
sons, 90.3% are male and only 9.7% are female. The same
values are shown in infection with HBV whereas a little
grow is shown in infection with HCV where female sex is
represented with 14.6% (Figure 2)
The most of infected persons with HBV and HCV belongs
to age group from 20–29 years and from 30–39 years.
Higher number is registered in age group from 30–39
years with value of 34.8%, whereas age group from 20–29
years is represented with 33.3%. The less value is shown
in age group over 50 year with 4.9%. The average of
infected persons is 32.2 year with SD 9.4 (Table 2)
The blood donors which samples were analyzed belong to
different occupations. However, the highest number, 842
(26.8%) were workers, followed by pupils with 7.3%. The
lowest number was among traders, 3.1%, (Figure 3).
Discussion
Infection with HBV and HCV are worldwide significant
problem in public health [13-18]. About 5% (300 mil-
lions), of world population has chronic infection HBV,
which is major factor for developing of chronic liver cir-
rhosis and carcinoma hepatocelulare [19-23].
According to CDC estimation about 3.9 million people
worldwide are infected with HCV, with highest prevalence
among age group 30–39 year and about 8000–10 000
death/year from lives disease caused from HCV infection,
(CDC, 1998).
The prevalence of HCV in world level can be more than
3%, [1,24-27].
Out of 70348 samples of the blood donors, 3145 were
positive. From overall positive samples, 2939 were HBV
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positive, 192 HCV positive while 14 samples were positive
for both viruses.
The HBV prevalence among the blood donors of Kosovo
is 4.2%, which range Kosovo to the second zone accord-
ing to the CDC classification of the geographical spread of
the HBV infection.
According to the study done in 1992 among blood donors
in Kosovo, the prevalence of HBV was 12, 05%, [21]. We
can conclude that after the adequate preventives measures
in this period, the prevalence of HBV is decreased signifi-
cantly.
The prevalence of HBV in dialyses patients in Kosovo is
24.2%, [28]. We think that such highest prevalence is
caused because of continually percutane blood exposure.
The HCV prevalence among the blood donors in Kosovo
is 0.3%. Compared to the other European countries this
level of prevalence is relatively low.
According to the WHO, the world prevalence with HCV is
3.1% [29,30]. The highest prevalence is in Africa, 5.3%,
whereas the lowest prevalence is in Europe, 1.03%, [30].
The highest prevalence of HCV between countries in
whole the world is in Egypt, 6–28% (mean 22%), [19,31-
33].
We can conclude that lower prevalence of HCV in Kosovo
is because here are not a lot of people living in high-risk
groups for infection with HCV.
The prevalence of HCV among dialyses patients in Kosovo
is 38.8%, [28]. This finding can confirm the meaning that
long exposure to blood and blood products is with high
risk for infection with HCV.
Age group 30–39 years old was presented with 34.8% of
cases. The higher number was among the workers, 842 or
26.8%.
Conclusion
￿ Prevalence of HBV among blood donors in Kosovo is
4.2%.
￿ Prevalence of HCV among blood donors in Kosovo is
0.3%.
Table 1: Prevalence of HBV and HCV, Kosovo 2000–2003, by 
type.
Type of Infection HBV HCV Total
N% N %N%
Mono-infection 2939 99.5 192 93.2 3131 99.6
Bi-infection 14 0.5 14 6.8 14 0.4
Total 2953 100.0 206 100.0 3145 100.0
Infection with HBV and HCV among blood donors in Kosovo, 2000–2003 By type and sex Figure 2
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￿ Based on the results we can conclude that we have the
similar prevalence for HBV and HCV infections as other
southeast European countries.
Proposition of measures
￿ To ensure health education activities among population
regarding those infections,
￿ To effort programs and projects which mean the activi-
ties with risk group population insisting of them to use
condoms and another protection measures during sexual
activities and professional care.
￿ To find sources for completing the lab with best tests
such are RIBA and PCR.
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